XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
OPERATING SEGMENTS AND GEOGRAPHIC INFORMATION (Tables)
6 Months Ended
Jun. 30, 2020
OPERATING SEGMENTS  
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2019 net sales and oeprating income

December 31, 2019

  

  

  

  

  

Discontinued

  

2019 Reported

Fixed

2019 Reported

Operations and

2019 Revised

Valued at 2019

  

Segment

  

Currency

  

Valued at 2020

  

Related Allocation

  

Valued at 2020

(millions)

Management Rates

  

Change

  

Rate Change

  

Management Rates

  

Charges

  

Management Rates

Net Sales

  

  

  

  

Global Industrial

$5,569.9

$479.2

$(52.7)

$5,996.4

$(1.8)

$5,994.6

Global Institutional

5,235.5

(800.1)

(23.3)

4,412.1

-

4,412.1

Global Healthcare and Life Sciences

-

991.7

(12.7)

979.0

-

979.0

Upstream Energy

-

2,350.0

2.9

2,352.9

(2,352.9)

-

Global Energy

3,334.0

(3,334.0)

-

-

-

-

Other

907.5

313.2

(9.0)

1,211.7

-

1,211.7

Subtotal at fixed currency rates

15,046.9

-

(94.8)

14,952.1

(2,354.7)

12,597.4

Effect of foreign currency translation

(140.6)

-

94.8

(45.8)

10.4

(35.4)

Consolidated reported GAAP net sales

$14,906.3

$-

$-

$14,906.3

$(2,344.3)

$12,562.0

Operating Income

Global Industrial

$854.7

$133.4

$(7.5)

$980.6

$(77.9)

$902.7

Global Institutional

1,042.2

(93.4)

(1.5)

947.3

(7.5)

939.8

Global Healthcare and Life Sciences

-

136.7

(1.6)

135.1

(10.6)

124.5

Upstream Energy

-

188.2

(0.3)

187.9

(187.9)

-

Global Energy

379.1

(379.1)

-

-

-

-

Other

167.3

14.2

(0.9)

180.6

(13.6)

167.0

Corporate

(409.1)

-

1.2

(407.9)

128.2

(279.7)

Subtotal at fixed currency rates

2,034.2

-

(10.6)

2,023.6

(169.3)

1,854.3

Effect of foreign currency translation

(20.4)

-

10.6

(9.8)

0.7

(9.1)

Consolidated reported GAAP operating income

$2,013.8

$-

$-

$2,013.8

$(168.6)

$1,845.2

Schedule of financial information for each of the entity's reportable segments

Second Quarter Ended

Six Months Ended 

June 30

June 30

(millions)

    

2020

2019

2020

2019

Net Sales

Global Industrial

 

$1,475.6

$1,500.7

$2,919.2

$2,897.7

Global Institutional

722.4

1,112.5

1,794.5

2,132.7

Global Healthcare and Life Sciences

307.6

252.8

554.1

479.8

Other

247.1

306.2

524.7

580.9

Corporate

12.3

-

12.3

-

Subtotal at fixed currency rates

2,765.0

3,172.2

5,804.8

6,091.1

Effect of foreign currency translation

(79.3)

(3.1)

(98.5)

2.7

Consolidated reported GAAP net sales

 

$2,685.7

 

$3,169.1

$5,706.3

$6,093.8

Operating Income

Global Industrial

 

$283.0

$220.9

$489.6

$382.3

Global Institutional

(37.0)

234.4

145.4

409.2

Global Healthcare and Life Sciences

65.6

31.2

88.5

56.0

Other

21.3

41.8

42.9

67.5

Corporate

(126.7)

(62.7)

(181.3)

(136.1)

Subtotal at fixed currency rates

206.2

465.6

585.1

778.9

Effect of foreign currency translation

(14.2)

(1.2)

(16.9)

(0.9)

Consolidated reported GAAP operating income

 

$192.0

 

$464.4

$568.2

$778.0